Andere Sprachen Evaxion A/S

Aktien

A40Z30

US29970R3030

EVAX

Biotechnologie

Realtime-Estimate Cboe BZX Andere Börsenplätze 15:42:07 09.12.2025			% 5 Tage	Veränd. 1. Jan.
6,300 ^USD	+0,32 %		+15,55 %	+48,57 %

08.12.	Europäische Aktien als ADRs in den USA am Montag kaum verändert	MT
01.12.	Europäische Aktien als American Depositary Receipts legen am Montag im US-Handel zu	MT

Andere Sprachen

European Equities Traded in the US as ADRs Little Changed in Monday Trading	08.12.
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting	06.12.
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	01.12.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week	28.11.
European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading	26.11.
European Equities Traded in the US as American Depositary Receipts Little Changed in Monday Trading	24.11.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down 3% for Week	21.11.
Evaxion A/S prospectus relates to offer and sale by selling shareholder of up to 38,450,000 ordinary shares	21.11.
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	20.11.
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1	20.11.
Evaxion A/S Announces Positive Data for Lead Antigens in Cytomegalovirus Vaccine Program Evx-V1	20.11.
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1	20.11.
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading	19.11.
European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading	13.11.
Evaxion announce 2026 financial calendar	12.11.
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	11.11.
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01	07.11.
European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Down Modestly for Week	07.11.
Evaxion A/S : Interim report Q3 2025 (Transcript)	07.11.
Evaxion A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	06.11.
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading	06.11.
Evaxion A/S : Interim report Q3 2025 (Release)	06.11.
Techbio firm Evaxion posts Q3 net income of $4.6 mln	06.11.
Evaxion announces business update and third quarter 2025 financial results	06.11.
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate	03.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Evaxion A/S

Aktien

A40Z30

US29970R3030

EVAX

Biotechnologie

Andere Sprachen

Filter